Clinical Trial Update: A Research Study of a New Medicine NNC0519-0130 in Japanese and Non-Japanese Men [Phase 1]

View source ↗

Summary

A Phase 1 study of the investigational medicine NNC0519-0130 in Japanese and non-Japanese men with Type 2 diabetes mellitus has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Type 2 Diabetes Mellitus

Drugs mentioned

• NNC0519-0130

Snippet

Sponsor: Novo Nordisk A/S | Conditions: Diabetes Mellitus, Type 2 | Phase 1 | Status: COMPLETED